Domínguez-Ortega J, Abad-Schilling C, Kindelan C
Unit of Allergology, Hospital Universitario de Getafe, Madrid, Spain.
Allergol Immunopathol (Madr). 2007 Jan-Feb;35(1):38-9. doi: 10.1016/s0301-0546(07)70228-8.
Calcium salts are often prescribed in the prevention and treatment of osteoporosis. Adverse reactions have been described, mostly concerning to the gastrointestinal tract, parathyroid glands and bone resorption. We report the case of a 52-year-old woman who started treatment with 500 mg per day of calcium-pidolate. 90 minutes after the intake of the second dose, she experienced an itchy maculopapular eruption. Skin Prick Tests were carried out with the implicated drug and calcium-carbonate and they both were negatives. An oral-challenge-test with 500 mg of calcium-pidolate was ruled out. 60 minutes later, the patient responded positively when she experienced a similar reaction with erythematous and itchy papulae on the trunk and the neck. Finally, an oral-challenge-test with 500 mg calcium-carbonate was performed with good tolerance. To the best of our knowledge, this is the first documented case of allergy to calcium-pidolate with tolerance to other calcium salt.
钙盐常用于骨质疏松症的预防和治疗。不良反应已有报道,主要涉及胃肠道、甲状旁腺和骨吸收。我们报告了一例52岁女性的病例,她开始每天服用500毫克的匹多酸钙进行治疗。在服用第二剂后90分钟,她出现了瘙痒性斑丘疹。对可疑药物和碳酸钙进行了皮肤点刺试验,结果均为阴性。排除了用500毫克匹多酸钙进行口服激发试验。60分钟后,当患者躯干和颈部出现类似的红斑和瘙痒性丘疹反应时,反应呈阳性。最后,对500毫克碳酸钙进行口服激发试验,耐受性良好。据我们所知,这是首例有记录的对匹多酸钙过敏但对其他钙盐耐受的病例。